Medicinal cannabis for treating PTSD and comorbid depression: Real World Evidence from Project T21
Blog
At Drug Science we like to cover different topics relating to drugs. These topics cover the many different ways that psychoactive substances have an impact on our culture and society.
- Dec 12, 2023
- 3 min
UK’s largest medical cannabis study announces new industry partners
- May 25, 2023
- 2 min
Medicinal cannabis for pain: Real-world data on three-month changes in symptoms and quality of life
- May 5, 2023
- 2 min
Characteristics of and 3-month health outcomes for people seeking treatment with prescribed cannabis
- Mar 23, 2023
- 2 min
Preliminary findings from T21 Australia
- Mar 20, 2023
- 2 min
Combating the stigma: a T21 success story
- Feb 24, 2023
- 2 min
Grow Pharma joins T21
- Feb 13, 2023
- 3 min
Parents and scientists back new study into benefits of cannabis-based medications for children with severe epilepsy
- Jan 24, 2023
- 1 min
Drug Science’s medical cannabis patient registry (T21) sees departure of Lyphe Group and introduces new pricing model
- Jan 16, 2023
- 4 min
Drug Science’s medical cannabis patient registry (T21) to continue for a fourth year
- Feb 8, 2022
- 2 min
Medical Cannabis study Project Twenty21 begins in Australia
- Jan 6, 2022
- 4 min
Project Twenty21 in 2022: A Message for Patients
- Sep 14, 2021
- 3 min
Project Twenty21 - September Update
- Aug 10, 2021
- 4 min
Project Twenty21 - August Update
- Jul 13, 2021
- 4 min
Project Twenty21 - July Update
- Jun 9, 2021
- 3 min
Project Twenty21 - June Update
- Mar 12, 2021
- 3 min
Project Twenty21 - March Update
- Mar 9, 2021
- 2 min
Statement Regarding Project Twenty21 and its Official Industry Partners
- Dec 14, 2020
- 2 min
Ending the pain of children with severe epilepsy?
- Dec 7, 2020
- 4 min
End of year update - 2020
- Oct 16, 2020
- 4 min
Project Twenty21 - an eventful first year!